GS-4528

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-4528, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-4528 in Adults With Solid Tumors [Phase 1]